Lysine-Specific Demethylase 1 (LSD1)-Mediated Epigenetic Modification of Immunogenicity and Immunomodulatory Effects in Breast Cancers.
Tumor evolution to evade immune surveillance is a hallmark of carcinogenesis, and the modulation of tumor immunogenicity has been a challenge to present therapeutic responses in immunotherapies alone for numerous cancers. By altering the cell phenotype and reshaping the tumor microenvironment, epige...
| Published in: | Current Oncology Vol. 30; no. 2; pp. 2127 - 2144 |
|---|---|
| Main Authors: | , , |
| Format: | Journal Article |
| Published: |
MDPI
Feb2023
|
| Online Access: | View this record in EBSCOhost |